Maria Lucia L. Madariaga

Maria Lucia L. Madariaga

Auto-generated profile, based on publicly available information

Maria Lucia L. Madariaga

Department of Surgery, University of Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Immunity
Verified
Journal Article
Closed access
HDHaley L. Dugan
Haley L. Dugan
CSChristopher T. Stamper
Christopher T. Stamper
LLLei Li
Lei Li
SCSiriruk Changrob
Siriruk Changrob
NANicholas W. Asby
Nicholas W. Asby
PWPatrick Wilson
Patrick Wilson

1 June 2021 in Matter
Verified
Journal Article
Closed access
MCMin Chen
Min Chen
JRJillian Rosenberg
Jillian Rosenberg
XCXiaolei Cai
Xiaolei Cai
ALAndy Chao Hsuan Lee
Andy Chao Hsuan Lee
JSJiuyun Shi
Jiuyun Shi
JHJun Huang
Jun Huang

9 October 2020 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
MMMaria Lucia L. Madariaga
Maria Lucia L. Madariaga
JGJenna J. Guthmiller
Jenna J. Guthmiller
SSStephen Schrantz
Stephen Schrantz
MJMaud O. Jansen
Maud O. Jansen
CCChancey Christensen
Chancey Christensen
JDJessica S. Donington
Jessica S. Donington
Background: Convalescent plasma therapy for COVID‐19 relies on transfer of anti‐viral antibody from donors to recipients via plasma transfusion. The relationship between clinical characteristics and antibody response to COVID‐19 is not well defined. We investigated predictors of convalescent antibody production and quantified recipient antibody response in a convalescent plasma therapy clinical trial.Methods: Multivariable analysis of clinical and serological parameters in 103 confirmed COVID‐19 convalescent plasma donors 28 days or more following symptom resolution was performed. Mixed‐effects regression models with piecewise linear trends were used to characterize serial antibody responses in 10 convalescent plasma recipients with severe COVID‐19.Results: Donor antibody titres ranged from 0 to 1 : 3892 (anti‐receptor binding domain (RBD)) and 0 to 1 : 3289 (anti‐spike). Higher anti‐RBD and anti‐spike titres were associated with increased age, hospitalization for COVID‐19, fever and absence of myalgia (all P < 0.05). Fatigue was significantly associated with anti‐RBD (P = 0.03). In pairwise comparison amongst ABO blood types, AB donors had higher anti‐RBD and anti‐spike than O donors (P < 0.05). No toxicity was associated with plasma transfusion. Non‐ECMO recipient anti‐RBD antibody titre increased on average 31% per day during the first three days post‐transfusion (P = 0.01) and anti‐spike antibody titre by 40.3% (P = 0.02).Conclusion: Advanced age, fever, absence of myalgia, fatigue, blood type and hospitalization were associated with higher convalescent antibody titre to COVID‐19. Despite variability in donor titre, 80% of convalescent plasma recipients showed significant increase in antibody levels post‐transfusion. A more complete understanding of the dose‐response effect of plasma transfusion amongst COVID‐19‐infected patients is needed.

1 October 2021 in Respiratory Medicine
Verified
Journal Article
Closed access
AAAbhinav Agrawal
Abhinav Agrawal
BBBrandon J. Baird
Brandon J. Baird
MMMaria Lucia L. Madariaga
Maria Lucia L. Madariaga
EBElizabeth A. Blair
Elizabeth A. Blair
SMSeptimiu Murgu
Septimiu Murgu

14 July 2022 in Digital Biomarkers
Verified
Journal Article
Open access
PDF file
DRDaniel S. Rubin
Daniel S. Rubin
SRSylvia L. Ranjeva
Sylvia L. Ranjeva
JUJacek K. Urbanek
Jacek K. Urbanek
MKMarta Karas
Marta Karas
MMMaria Lucia L. Madariaga
Maria Lucia L. Madariaga
MHMegan Huisingh-Scheetz
Megan Huisingh-Scheetz
Background: Functional capacity assessment is a critical step in the preoperative evaluation to identify patients at increased risk of cardiac complications and disability after major noncardiac surgery. Smartphones offer the potential to objectively measure functional capacity but are limited by inaccuracy in patients with poor functional capacity. Open-source methods exist to analyze accelerometer data to estimate gait cadence (steps/min), which is directly associated with activity intensity. Here, we used an updated Step Test smartphone application with an open-source method to analyze accelerometer data to estimate gait cadence and functional capacity in older adults. Methods: We performed a prospective observational cohort study within the Frailty, Activity, Body Composition and Energy Expenditure in Aging study at the University of Chicago. Participants completed the Duke Activity Status Index (DASI) and performed an in-clinic 6-min walk test (6MWT) while using the Step Test application on a study smartphone. Gait cadence was measured from the raw accelerometer data using an adaptive empirical pattern transformation method, which has been previously validated. A 6MWT distance of 370 m was used as an objective threshold to identify patients at high risk. We performed multivariable logistic regression to predict walking distance using a priori explanatory variables. Results: Sixty patients were enrolled in the study. Thirty-seven patients completed the protocol and were included in the final data analysis. The median (IQR) age of the overall cohort was 71 (69–74) years, with a body mass index of 31 (27–32). There were no differences in any clinical characteristics or functional measures between participants that were able to walk 370 m during the 6MWT and those that could not walk that distance. Median (IQR) gait cadence for the entire cohort was 110 (102–114) steps/min during the 6MWT. Median (IQR) gait cadence was higher in participants that walked more than 370 m during the 6MWT 112 (108–118) versus 106 (96–114) steps/min; p = 0.0157). The final multivariable model to identify participants that could not walk 370 m included only median gait cadence. The Youden’s index cut-point was 107 steps/min with a sensitivity of 0.81 (95% CI: 0.77, 0.85) and a specificity of 0.57 (95% CI: 0.55, 0.59) and an AUCROC of 0.69 (95% CI: 0.51, 0.87). Conclusions: Our pilot study demonstrates the feasibility of using gait cadence as a measure to estimate functional capacity. Our study was limited by a smaller than expected sample size due to COVID-19, and thus, a prospective study with preoperative patients that measures outcomes is necessary to validate our findings.

1 February 2022 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MMMaria Lucia L. Madariaga
Maria Lucia L. Madariaga
MSMonica L. Soni
Monica L. Soni
DMDouglas J. Mathisen
Douglas J. Mathisen
CWCameron D. Wright
Cameron D. Wright
SLShuben Li
Shuben Li
HGHenning A. Gaissert
Henning A. Gaissert